Urgent Product Recall: Accu-Chek Solo cannula assembly and pump holder and Accu-Chek Solo supply kit 22 December 2022 The Therapeutic Goods Administration (TGA) and Roche Diabetes Care have issued an urgent medical device recall for Accu-Chek Solo cannula assembly and pump holder, and the supply kit. Roche Diabetes Care has identified that insulin leakage has occurred in a small number of cases with the Accu-Chek Solo cannula assembly and pump holder (6mm and 9mm, NDSS codes 851 and 852) and the Accu-Chek Solo supply kit (6mm and 9mm). Discontinue use of these products immediately. The insulin leakage may not be noticed straight away, which could lead to an under-delivery of insulin. The possible consequences could range from no clinical impact to severe hypoglycaemia (dangerously low blood glucose levels) or diabetic ketoacidosis (DKA). Please contact Roche Diabetes customer care on 1800 251 816 for information on how to return the impacted stock and receive the replacement. The complete recall notice from the TGA is available here.
News 12 December 2024 Expanded access to cheaper medicines for Australians living with type 2 diabetes Diabetes Australia thanks the Albanese Government for its decision to expand the Pharmaceutical Benefits Scheme (PBS) listings for Forxiga® and... Continue Reading
News 12 December 2024 Overweight and obesity overtakes smoking as leading health risk Being overweight and obese is now risking more Australians’ health than smoking according to new data, as a new government... Continue Reading
Media releases 4 December 2024 Diabetes Australia announces $40 million for research Diabetes Australia has announced it will invest $40 million in diabetes research over the next 10 years. In light of... Continue Reading